Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib.
Br J Haematol
; 190(1): e48-e51, 2020 07.
Article
in En
| MEDLINE
| ID: mdl-32358888
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Triazines
/
Aminopyridines
/
Isocitrate Dehydrogenase
/
Myeloproliferative Disorders
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Haematol
Year:
2020
Type:
Article
Affiliation country:
United States